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Stem cells are the body’s “master” cells because they give rise to all other tissues, organs, andsystems in the body. Each tissue within the body contains unique type of stem cells that renew
and replace that particular tissue (e.g. nerve, brain, cartilage, blood) when needed, due to damage
or wear and tear.  Stem cells have the remarkable potential to develop into many different cell
types in the body. Basically, these cells serve as a sort of repair system for the body; they can
theoretically divide without limit to replenish other cells as long as the person or any other living
being is still alive. When a stem cell divides, each new cell has the potential to either remain a stem
cell or become another type of cell with a more specialized function, such as a muscle cell, a red
blood cell, or a brain cell. The classical definition of a stem cell requires that it possess the following
two properties :
Self-renewal - the ability to go through numerous cycles of cell division while maintaining the
undifferentiated states
PLuripotency - the capacity to differentiate into specialized cell types. In the strictest sense,
this requires stem cells to be either totipotent or pluripotent - to be able to give rise to any mature
cell type, although multipotent or unipotent progenitor cells are sometimes referred to as stem
cells
Totipotent cells are considered the “master” cells of the body because they contain all the
genetic information needed to create all the cells of the body plus the placenta, which nourishes
the  embryo. Human cells have this capacity only during the first few divisions of a fertilized egg.
After 3 - 4 divisions of totipotent cells, there follows a series of stages in which the cells become
increasingly specialized. The next stage of division results in pluripotent cells, which are highly
versatile and can give rise to any cell type except the cells of the placenta. At the next stage, cells
become multipotent, meaning they can give rise to several other cell types, but those types are
limited in number. An example of multipotent cells is hematopoietic cells—blood stem cells that
can develop into several types of blood cells, but cannot develop into brain cells. At the end of the
long chain of cell divisions that make up the embryo are “terminally differentiated” cells (cells that
are considered to be permanently committed to a specific function).
Pluripotent stem cells are isolated from embryos that are a few days old. Cells from these
embryos can be used to create pluripotent stem cell “lines” —cell cultures that can be grown
indefinitely in the laboratory.
The two broad types of vertebrate stem cells are:
Embryonic stem cells that are found in blastocysts and Adult stem cells that are found in adult
tissues.
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In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues.
In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing
specialized cells, but also maintain the normal turnover of regenerative organs, such as blood, skin
or intestinal tissues.
As stem cells can be grown and transformed into specialized cells with characteristics consistent
with cells of various tissues such as muscles or nerves through cell culture, their use in medical
therapies has been proposed. In particular, embryonic stem cell lines, autologous embryonic stem
cells generated through therapeutic cloning, and highly plastic adult stem cells from the umbilical
cord blood or bone marrow are considered as promising candidates.
Identifying Stem Cells
The practical definition of a stem cell is the functional definition - the ability to regenerate
tissue over a lifetime. For example, the gold standard test for a bone marrow or hematopoietic
stem cell (HSC) is the ability to transplant one cell and save an individual without HSCs. In this case,
a stem cell must be able to produce new blood cells and immune cells over a long term,
demonstrating potency. It should also be possible to isolate stem cells from the transplanted
individual, which can themselves be transplanted into another individual without HSCs,
demonstrating that the stem cell was able to self-renew.
Properties of stem cells can be illustrated in vitro, using methods such as clonogenic assays,
where single cells are characterized by their ability to differentiate and self-renew. As well, stem
cells can be isolated based on a distinctive set of cell surface markers. However, in vitro culture
conditions can alter the behavior of cells, making it unclear whether the cells will behave in a
similar manner in vivo. Considerable debate exists whether some proposed adult cell populations
are truly stem cells.
Embryonic stem cell lines (ES cell lines) are cultures of cells derived from the epiblast tissue of
the inner cell mass (ICM) of a blastocyst or earlier morula stage embryos. ES cells are pluripotent
and during development, give rise to all derivatives of the three primary germ layers: ectoderm,
endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell
types of the adult body when given sufficient and necessary stimulation for a specific cell type.
They do not contribute to the extra-embryonic membranes or the placenta.
A human embryonic stem cell is also defined by the presence of several transcription factors
and cell surface proteins. The transcription factors Oct-4, Nanog, and Sox2 form the core regulatory
network that ensures the suppression of genes that lead to differentiation and the maintenance of
pluripotency. The cell surface antigens most commonly used to identify hES cells are the glycolipids
SSEA3 and SSEA4 and the keratan sulfate antigens Tra-1-60 and Tra-1-81. The molecular definition
of a stem cell includes many more proteins and continues to be a topic of research.
ES cells, being totipotent cells, require specific signals for correct differentiation - if injected
directly into the body, ES cells will differentiate into many different types of cells, causing a teratoma.
Differentiating ES cells into usable cells while avoiding transplant rejection are just a few of the
hurdles that embryonic stem cell researchers still face. Many nations currently have moratoria on
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either ES cell research or the production of new ES cell lines. Because of their combined abilities of
unlimited expansion and pluripotency, embryonic stem cells remain a theoretically potential source
for regenerative medicine and tissue replacement after injury or disease.
Adult stem cells
The term adult stem cell refers to any cell which is found in a developed organism that has two
properties: the ability to divide and create another cell like itself and also divide and create a cell
more differentiated than itself.  Pluripotent adult stem cells are rare and generally small in number
but can be found in a number of tissues including umbilical cord blood. Most adult stem cells are
lineage-restricted (multipotent) and are generally referred to by their tissue origin (mesenchymal
stem cell, adipose-derived stem cell, endothelial stem cell, etc.)
A great deal of adult stem cell research has focused on clarifying their capacity to divide or self-
renew indefinitely and their differentiation potential. In mice, pluripotent stem cells are directly
generated from adult fibroblast cultures.
While embryonic stem cell potential remains untested, adult stem cell treatments have been
used for many years to treat successfully leukemia and related bone/blood cancers through bone
marrow transplants. The use of adult stem cells in research and therapy is not as controversial as
embryonic stem cells, because the production of adult stem cells does not require the destruction
of an embryo. Consequently, more US government funding is being provided for adult stem cell
research.
Lineage
To ensure self-renewal, stem cells undergo two types of cell division. Symmetric division gives
rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division,
on the other hand, produces only one stem cell and a progenitor cell with limited self-renewal
potential. Progenitors can go through several rounds of cell division before terminally differentiating
into a mature cell. It is possible that the molecular distinction between symmetric and asymmetric
divisions lies in differential segregation of cell membrane proteins (such as receptors) between the
daughter cells. An alternative theory is that stem cells remain undifferentiated due to environmental
cues in their particular niche. The signals that lead to reprogramming of cells to an embryonic-like
state are also being investigated. These signal pathways include several transcription factors including
the oncogene c-Myc. Initial studies indicate that transformation of mice cells with a combination of
these anti-differentiation signals can reverse differentiation and may allow adult cells to become
pluripotent. However, the need to transform these cells with an oncogene may prevent the use of
this approach in therapy.
Applications of Stem Cells
Stems cells – whether cord blood, adult or embryonic – have numerous applications in the
areas of scientific research and cell therapy. For researchers, stem cells are the key to understanding
how humans develop the way they do. Hopefully, the study of stem cells will unravel the mystery of
how an undifferentiated cell is able to differentiate, and will also determine what is the signal that
triggers the sequence. The greater understanding, and possibly even control, of cell division and
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differentiation is a significant strategy in the battle against dreaded illnesses such as cancer, which
is basically the continuous multiplication of abnormal cells.
The use of stem cells for the testing of new medicines is another highly-anticipated application.
Although certain cells are already utilized for this purpose – cancer cells, for example, are used to
tests anti-tumor drugs – testing on pluripotent cells would open up this field to a much broader
number of cell types.
The third, and possibly most important, application is cell therapy, which is the use of stem
cells to produce the cells and tissues required for the renewal or repair of body organs that have
been damaged by debilitating and mortal diseases such as cancer, spinal cord injuries, glaucoma
and Parkinson’s disease.
Stem cells provide the opportunity to study the growth and differentiation of individual cells
into tissues. Understanding these processes could provide insights into the causes of birth defects,
genetic abnormalities, and other disease states. If normal development were better understood, it
might be possible to prevent or correct some of these conditions. Stem cells could be used to
produce large amounts of one cell type to test new drugs for effectiveness and chemicals for toxicity.
Stem cells might be transplanted into the body to treat disease (diabetes, Parkinson’s disease) or
injury (e.g., spinal cord). The damaging side effects of medical treatments might be repaired with
stem cell treatment. For example, cancer chemotherapy destroys immune cells in patients,
decreasing their ability to fight off a broad range of diseases; correcting this adverse effect would
be a major advance.
Before stem cells can be applied to human medical problems, substantial advances in basic cell
biology and clinical technique are required. In addition, very challenging regulatory decisions will
be required on the individually created tissue-based therapies resulting from stem cell research.
Such decisions would likely be made by the Center for Biologics Evaluation and Research (CBER) of
the Food and Drug Administration (FDA). The potential benefits mentioned above would be likely
only after many more years of research. Technical hurdles include developing the ability to control
the differentiation of stem cells into a desired cell type (like a heart or nerve cell) and to ensure that
uncontrolled development, such as a cancerous tumor, does not occur. Some experiments may
involve the creation of a chimera, an organism that contains two or more genetically distinct cell
types, from the same species or different species. If stem cells are to be used for transplantation,
the problem of immune rejection must also be overcome. It is hoped  that the creation of many
more embryonic stem cell lines will eventually account for all the various immunological types
needed for use in tissue transplantation therapy. Others envision the eventual development of a
“universal donor” type of stem cell tissue, analogous to a universal blood donor. However, if the
Somatic Cell Nuclear Transfer (SCNT) technique/cloning was employed using a cell nucleus from
the patient, stem cells created via this method would be genetically identical to the patient, would
presumably be recognized by the patient’s immune system, and thus would avoid any tissue rejection
problems that could occur in other stem cell therapeutic approaches. Because of this, many scientists
believe that the SCNT technique may provide the best hope of eventually treating patients using
stem cells for tissue transplantation.
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ES cell cultures from piscine species
Embryonic stem (ES) cells are undifferentiated cells derived from early developing embryos of
animals, characterised by their capacity for self-renewal and pluripotency. These cells retain their
pluripotency after long-term cultivation in vitro and can be induced to differentiate into a variety of
cell types. When introduced into host embryo, the ES cells can participate in normal development
and contribute to several tissues of the host, including cells of the germ line. These characteristics
make ES cells ideal experimental systems for in vitro studies of embryonic cell development and
differentiation and a vector for the efficient transfer of foreign DNA into the germ line of an organism.
In addition, ES cells provide an attractive strategy for the preservation of biodiversity (Hong et al.,
1996). These cells have the potential to produce any type of cell of the body and can be propagated
in unlimited quantities, which  led to the  importance  of human ES cells (hESCs) in regenerative
medicine and treatment of a variety of diseases.
In spite of the discouraging situation encountered in other animal species, fish are especially
suited for developing ES cell technology for two reasons viz., piscine species are of considerable
interest for both basic studies in molecular, cellular, and developmental biology as well as for
commercial interest. As model vertebrate organisms, zebrafish and medaka are competitive with
mouse for the analysis of gene functions relevant to humans. In the aquaculture activity, there is an
increasing interest for incorporating new fish species for diversification. Fish have several technical
advantages over other vertebrates such as high fecundity, large transparent embryos, and rapid
development. Fish embryos often develop outside the mother, which is a big advantage for initiating
embryonic stem cell cultures from fish compared to mouse. The starting point is the mid-blastula
(MB) embryo. The first goal in developing fish ES cells was to establish conditions that supported
growth of the embryonic stem cells while avoiding spontaneous differentiation. ES cell-mediated
gene transfer is a promising approach for producing site mutated transgenic fish with enhanced
growth rates or disease resistance, as well as for analyzing functions of fish genes (Melamed et al.,
2002). ES cells along with other cellular based strategies, such as primordial germ cells and nuclear
transfer, allow selecting the desired transformation events before transferring the transgene to the
whole animal.
Another important aspect of piscine cells is their lowest position in the ladder of evolution,
which makes them suitable for xenotransplantation in mammals (Wright and Yang, 1997; Laue et
al., 2001; Wright and Pohajdak, 2001). The islet tissue in certain teleost fish like tilapia called
Brockmann bodies has been shown to restore normoglycemia on transplantation into diabetic nude
mice (Wright and Pohajdak, 2001). Similarly, reversal of streptozotocin-diabetes has been achieved
after transplantation of piscine islets to nude mice (Laue et al., 2001). These reports indicate potential
of piscine cells for clinical applications.
To develop ES cell lines and gene targeting techniques in fish, extensive studies have been
done in small model fishes such as zebrafish and medaka, because they offer the possibility of
combining embryological, genetic, and molecular analysis of vertebrate development. ES-like cell
lines have been established in medaka (Wakamatsu et al., 1994; Hong et al., 1996) and zebrafish
(Collodi et al., 1992; Sun et al., 1995). One medaka ES-like cell line, MES1, was shown to retain a
diploid karyotype and the ability to form viable chimeras (Hong   et al., 1998).
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Development of ES cell technology in model fish prompted application of feeder-free cell culture
conditions to commercial species. The main objective was to improve the productivity of farmed
fish by targeting genes related to commercial traits on ES cells, such as growth, or disease resistance.
A technical goal was to genetically modify fish by making germline chimeras or by nuclear transfer
(Bejar et al., 1999). The first, long-term, stable cell line from a commercial species was SaBE-1,
which was derived from the marine fish gilthead seabream (Bejar et al., 1999). From this cell line a
clonal culture was derived (SaBE-1c) that was screened for pluripotency in vitro and in vivo (Bejar et
al., 2002). Cells were characterized for proliferation, chromosome complement, alkaline phosphatase
staining, telomerase activity, and induction of cell differentiation. Chimeric fish have been made in
which all three embryonic germ layers are mosaic, but the efficiency was low in terms of survival
and contribution of the donor cells (Bejar et. al., 2002). Long-term embryonic cell lines have been
subsequently derived from species of commercial relevance in Asia. The first two were SBES1 from
red seabream, Pagrus major (Chen et al., 2003a) and LJES1 from sea perch, Lateolabrax japonicus
(Chen et al., 2003b). These two lines have been maintained for more than 50 passages in vitro and
characterized for traits of pluripotency. They have been induced to differentiate into various cell
types after treatment with retinoic acid (RA). Holen and Hamre (2003) derived a long-term embryonic
stem cell–like culture from the turbot, Scophtalmus maximus and these cells expressed Oct4
transcription factor. Two other cell lines, FEC from the flounder (Chen et al., 2004) and TEC from
turbot, Scophthalmus maximus (Chen et al., 2005), have been developed and partially characterized.
More recently Chen et al. (2007) developed pluripotency and chimera competence of an embryonic
stem cell line from the sea perch (L. japonicus).
In spite of the feasibility of ES cell line derivation in commercial species, a main obstacle is the
production and evaluation of chimeric animals resulting from technical disadvantages when
compared with model species, including difficulties in handling and rearing, as well as long generation
times (2 to 3 years to reach sexual maturity). In this way only chimeras have been obtained so far in
the gilthead seabream and with low efficiency (Bejar et al., 2002). Because of the expensive and
time-consuming process, the methodology of chimera production must be optimized in model
species before application to commercial fish.
Fish embryonic stem cells - applications
There is scope for application of embryonic stem cell technology to commercial fish species to
improve productivity by transgenesis. Research efforts on development of transgenic fish with
enhanced resistance to pathogens and better growth and breeding performance/colour
manipulations in ornamental fishes will be beneficial to the development of aquaulture technologies.
ES cells, have the intrinsic ability to self-renew and can be applied to biodiversity rescuing, gene-
targeting and germ-line transmission. In fisheries, there is scope for application of  induced
pluripotent stem cells (iPSCs) which are produced by reprogramming adult somatic cells using
pluripotency genes, especially in the case of difficult to breed large sized marine fish species as well
as in the case of endangered species. In human medicine, stem cell research offers the possibility of
curing fatal and debilitating diseases; in aquaculture, it may enhance fish production and reduce
environmental risks. Stem cell lines that could potentially be used to modify the genetic traits of
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any fish species are being developed in different parts of the world. Fish ES/iPS cell lines have many
avenues for fish biology, functional genomics, molecular embryology and conservation of biodiversity.
The piscine embryonic stem (ES) cells have attracted the attention of fish breeders and molecular
biologists owing to its possible importance in producing transgenic fish with  site-directed integration
of foreign gene and in studying gene function in fish.  ES cells provide  unique tool for cell-mediated
gene transfer and targeted gene mutations due to the possibility of in vitro selection of desired
genotypes. When ES cells colonize germ cells in chimeras, transgenic animals with modified
phenotypes are generated and used either for functional genomics studies or for improving
productivity in commercial settings. Establishment of ES gene targeting techniques in cultured fish
provides a novel approach for genetic improvements; developmental biology and analysis of gene
function in fish.
Embryonic stem (ES) cells represent promising cellular vehicle for the production of genetically
modified fish. ES cells provide unique tool for cell-mediated gene transfer and targeted gene
mutations due to the possibility of in vitro selection of desired genotypes. When ES cells contribute
to the germ line in chimaeric embryos, transgenic animals may be generated with modified genetic
traits. Though the ES cell approach has up to now been limited to mice, there is an increasing
interest to develop this technology in both model and commercial fish species, with so far promising
results in the medaka (Oryzias latipes) and zebrafish (Danio rerio). ES cell lines have also potential
application for colour manipulations in ornamental fish and also as model systems for therapeutic
research in aquaculture.
Taking into consideration, the non-invasive and easy access to fish embryos due to its natural
oviparous mode of reproduction as compared to the viviparous mode of mammalian reproduction,
fish embryos neither evoke ethical issues nor involve invasive interventions. However, ethical issues
involved  in using human embryos for deriving ES cells have led to the development of induced
pluripotent stem cells (iPSCs). iPSCs are produced by reprogramming somatic cells using pluripotency
genes. iPSCs were first developed by Takahashi and Yamanaka (2006) from mouse fibroblasts and
later from human somatic cells by several workers (Thompson et al., 2007; Okita et al., 2008; Woltjen
et al., 2009). These pluripotent cells can differentiate into any type of cell in the body and proliferate
indefinitely in culture. In fisheries, there is scope for application of  iPS cell technology especially in
the case of difficult to breed large sized marine fish species as well as in the case of endangered
species. iPS cell lines developed by reprogramming primary fibroblasts from adult fish tissues could
be attempted for deriving germ cells and subsequently for development of surrogate broodstock
technology. Surrogate  broodstocking could be made use of especially  in the case of large aquaculture
species or endangered species of fish  by transplanting germ cells into small fish species that matures
fast, and then use the  eggs produced  for larval production. This technology has already been
attempted to produce eggs of endangered species of trout in salmon (Okutsu et al., 2009)
Laboratory fish species, in particular zebrafish and medaka, have been the focus of research
towards stem cell cultures. Medaka is the second organism (next mouse) that generated ES cells
and the first that gave rise to a spermatogonial stem cell line capable of test-tube sperm production.
Most recently, the first haploid stem cells capable of producing whole animals have also been
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generated from medaka. ES-like cells have also been reported in zebrafish and several marine species.
Attempts for germline transmission of ES cell cultures and gene targeting have been reported in
zebrafish. Recent years have witnessed the progress in markers and procedures for ES cell
characterization. These include the identification of fish homologs/paralogs of mammalian
pluripotency genes and parameters for optimal chimera formation. In addition, fish germ cell cultures
and transplantation have attracted considerable interest for germline transmission and surrogate
production. Haploid ES cell nuclear transfer has proven in medaka the feasibility of semi-cloning as
a novel assisted reproductive technology. These pioneer experiments demonstrate the possibility
of surrogate production of aquaculture broodstock by germ cell transplantation. This approach
might be extended to propagate/restore a population of endangered species in conservation biology.
The derivation of germ cells from fish embryonic stem cells (ESCs) or induced pluripotent stem
(iPSCs) cells represents a desirable experimental model and potential strategy for improving
reproductive performance of commercially important difficult to breed fish species. Moreover, ES
cells may be a method to preserve biodiversity in species for which embryo or gamete
cryopreservation is not possible. Recent progress in fish stem cell culture and transplantation will
provide valuable systems and tools for basic research and applications in sustainable aquaculture
and fish biodiversity conservation
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